SCIEX Debuts Breakthrough Acoustic Ejection Mass Spectrometry Technology at ASMS 2019

a global leader in life science analytical technologies, introduces
Acoustic Ejection Mass Spectrometry (AEMS) technology, a milestone for
the future of high-throughput quantification, at ASMS 2019. AEMS
technology, incorporating the Open Port Interface (OPI) and Acoustic
Droplet Ejection (ADE), has received unprecedented enthusiasm from
collaborators, leading SCIEX to introduce the technology ahead of
commercialization. SCIEX intends to bring the technology to market as
Echo MS.

Upon commercialization, Echo MS has the potential to redefine current
and future laboratory workflows in Pharma ADME, synthetic biology, food
testing and clinical research, opening a new frontier in contactless
sampling and delivering rich data sets. In early testing, AEMS
technology has shown the potential to reduce screening times, from 115
days to 4 days for 1 million compounds.

Additional achievements of AEMS technology include:

  • Up to 50x faster sample analysis, delivering rich data sets and
    reducing the risk of missing lead compounds
  • Accelerated speed of analysis, capable of up to 3 samples per second
    – 180 samples/min, 11,000 samples/hour, 260,000 samples/day
  • Low CV’s quantification (5–8%) , leading to high
    reproducibility regardless of the matrix
  • Sample analysis direct from the plate – no LC required,
    eliminating carry over and errors

“This latest achievement is truly an innovation for the industry. AEMS
technology demonstrates how we have once again pushed the boundaries of
what is possible in quantification, to enable our customers to maximize
their workflows and analyze samples faster than ever before,” says
Dominic Gostick, Vice President and General Manager, LC-MS, SCIEX.

AEMS technology is a breakthrough conceived by the Open Innovation
Project, a collaboration between SCIEX and The Department of Energy’s
Oak Ridge National Laboratory. Led by industry pioneer and SCIEX
Principal Research Scientist, Tom Covey, the Open Innovation Project
developed the OPI, a key part of AEMS technology.

For an exclusive view of the technology behind Echo MS, visit the SCIEX
Hospitality Suite at ASMS
[3] or[4].

For research use only. Not for use in diagnostic procedures.


AB Sciex is operating as SCIEX.

© 2019 AB Sciex. The trademarks mentioned herein are the property of the
AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used
under license.


SCIEX helps to improve the world we live in by enabling scientists and
laboratory analysts to find answers to the complex analytical challenges
they face. The company’s global leadership and world-class service and
support in the capillary electrophoresis and liquid chromatography-mass
spectrometry industry have made it a trusted partner to thousands of the
scientists and lab analysts worldwide who are focused on basic research,
drug discovery and development, food and environmental testing,
forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to
and understanding the ever-evolving needs of its customers to develop
reliable, sensitive and intuitive solutions that continue to redefine
what is achievable in routine and complex analysis. For more
information, please visit[5]

SCIEX social: @SCIEXnews[6]LinkedIn[7],
and Facebook[8].


  1. ^ (
  2. ^ SCIEX (
  3. ^ SCIEX Hospitality Suite at ASMS (
  4. ^ (
  5. ^ (
  6. ^ @SCIEXnews (
  7. ^ LinkedIn (
  8. ^ Facebook (

Source URL: Read More
The public content above was dynamically discovered – by graded relevancy to this site’s keyword domain name. Such discovery was by systematic attempts to filter for “Creative Commons“ re-use licensing and/or by Press Release distributions. “Source URL” states the content’s owner and/or publisher. When possible, this site references the content above to generate its value-add, the dynamic sentimental analysis below, which allows us to research global sentiments across a multitude of topics related to this site’s specific keyword domain name. Additionally, when possible, this site references the content above to provide on-demand (multilingual) translations and/or to power its “Read Article to Me” feature, which reads the content aloud to visitors. Where applicable, this site also auto-generates a “References” section, which appends the content above by listing all mentioned links. Views expressed in the content above are solely those of the author(s). We do not endorse, offer to sell, promote, recommend, or, otherwise, make any statement about the content above. We reference the content above for your “reading” entertainment purposes only. Review “DMCA & Terms”, at the bottom of this site, for terms of your access and use as well as for applicable DMCA take-down request.

Acquire this Domain
You can acquire this site’s domain name! We have nurtured its online marketing value by systematically curating this site by the domain’s relevant keywords. Explore our content network – you can advertise on each or rent vs. buy the domain. | Skype: TLDtraders | +1 (475) BUY-NAME (289 – 6263). Thousands search by this site’s exact keyword domain name! Most are sent here because search engines often love the keyword. This domain can be your 24/7 lead generator! If you own it, you could capture a large amount of online traffic for your niche. Stop wasting money on ads. Instead, buy this domain to gain a long-term marketing asset. If you can’t afford to buy then you can rent the domain.

About Us
We are Internet Investors, Developers, and Franchisers – operating a content network of several thousand sites while federating 100+ eCommerce and SaaS startups. With our proprietary “inverted incubation” model, we leverage a portfolio of $100M in valued domains to impact online trends, traffic, and transactions. We use robotic process automation, machine learning, and other proprietary approaches to power our content network. Contact us to learn how we can help you with your online marketing and/or site maintenance.